Illumina Sues Life Technologies Over Array Sensor Patent
This article is for subscribers only.
Illumina Inc., whose genetic analysis tools are used in disease research and drug development, sued Life Technologies Corp. claiming infringement of one of its patents.
Life Technologies’ Ion Personal Genome Machine and Ion OneTouch System infringe Illumina’s patent for a method of “making and decoding of array sensors with microspheres,” Illumina said in a complaint filed Dec. 27 in federal court in San Diego. The company seeks a court order stopping the alleged infringement and unspecified damages.